Vision
Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system.
Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.
News
16-19 Oct 2024
Epimune to attend and exhibit at 21st Biennial Meeting of the European Society for Immunodeficiency (ESID 2024, Marseille, France)
For a Spanish version of this video please click here!